The fact that the colon cancer cohort with high p21 expression exhibited a 23% higher 5-year survival rate compared to the low p21 expression cohort (Figure 5B) further strengthens the potential protective role of p21 protein against colon cancer. Here, CDKN1A is linked to colonic neoplasm.